Ivor MacLeod
Director of Finance/CFO at SCYNEXIS, INC.
Net worth: 235 506 $ as of 2024-03-30
Profile
Ivor MacLeod is currently the Chief Financial & Accounting Officer at SCYNEXIS, Inc. Prior to this, he held positions as Vice President-Finance at Merck & Co., Inc., Vice President-Finance & Information Technology at Hoffmann-La Roche, Inc., and Chief Financial & Compliance Officer, SVP at Eisai, Inc. From 2021 to 2022, he served as the Chief Financial & Accounting Officer at Athersys, Inc. Mr. MacLeod completed his undergraduate degree at the University of St. Andrews and holds an MBA from Eller College of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SCYNEXIS, INC.
0.43% | 2024-01-25 | 160,185 ( 0.43% ) | 235 472 $ | 2024-03-30 |
ATHERSYS, INC.
0.01% | 2023-08-13 | 5,732 ( 0.01% ) | 34 $ | 2024-03-30 |
Ivor MacLeod active positions
| Companies | Position | Start |
|---|---|---|
| SCYNEXIS, INC. | Director of Finance/CFO | 2022-10-23 |
Former positions of Ivor MacLeod
| Companies | Position | End |
|---|---|---|
| ATHERSYS, INC. | Director of Finance/CFO | 2022-06-29 |
| MERCK & CO., INC. | Director of Finance/CFO | - |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Director of Finance/CFO | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Director of Finance/CFO | - |
Training of Ivor MacLeod
| University of St. Andrews | Undergraduate Degree |
| Eller College of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SCYNEXIS, INC. | Health Technology |
| ATHERSYS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
- Stock Market
- Insiders
- Ivor MacLeod
